第VIII因子欠乏症治療の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Factor VIII Deficiency Treatment Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Highlights

PART 05: Deficiency overview

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Market segmentation by type of disease application
• Global hemophilia A drugs market
• Global hemophilia A inhibitors treatment market
• Global von Willebrand disease treatment market

PART 09: Market segmentation by type of therapy
• Recombinant therapies
• Plasma-derived therapies

PART 10: Market segmentation by type of disease management
• Prophylaxis
• On-demand therapy
• Inhibitor therapy

PART 11: Geographical segmentation
• Factor VIII deficiency treatment market in Americas
• Factor VIII deficiency treatment market in EMEA
• Factor VIII deficiency treatment market in APAC

PART 12: Market drivers
• Increasing adoption of prophylactic drugs
• Paradigm shift toward the development of drugs with extended half-life
• Large patient pool driving the shipments of factor VIII units

PART 13: Impact of drivers

PART 14: Market challenges
• Low diagnosis rate affecting the market growth
• High entry barriers
• Cost-intensive complex treatment

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Increase in technological innovations
• Development of gene therapy products
• Expansion initiatives of vendors fueling the market growth
• Increasing investments of vendors to improve the production capability

PART 17: Vendor landscape
• Competitive scenario

PART 18: Key vendor analysis
• Bayer HealthCare
• CSL
• Grifols
• Novo Nordisk
• Pfizer
• Shire
• Other prominent vendors

PART 19: Appendix
• List of abbreviation

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Process of gene therapy
Exhibit 03: Key buying criteria for global factor VIII deficiency treatment market 2016 and 2021
Exhibit 04: Key customer segments of factor VIII deficiency treatment market
Exhibit 05: Pipeline analysis as of 2016
Exhibit 06: Key clinical trials
Exhibit 07: Global factor VIII deficiency treatment market snapshot
Exhibit 08: Global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 09: Global factor VIII deficiency treatment market by volume 2016-2021 (million units)
Exhibit 10: Impact of factors affecting the market 2016 and 2021
Exhibit 11: Opportunity analysis in global factor VIII deficiency treatment market
Exhibit 12: Five forces analysis
Exhibit 13: Global factor VIII therapy in hemophilia A market 2016-2021 ($ millions)
Exhibit 14: Global factor VIII therapy in hemophilia A inhibitors market 2016-2021 ($ millions)
Exhibit 15: Global factor VIII therapy in von Willebrand disease treatment market 2016-2021 ($ millions)
Exhibit 16: Recombinant therapies in global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 17: Plasma-derived therapies in global factor VIII deficiency treatment market 2016-2021 ($ billions)
Exhibit 18: Segmentation of factor VIII drugs market by type of disease management based on revenue 2016
Exhibit 19: Segmentation of global factor VIII deficiency treatment market based on geography 2016 and 2021
Exhibit 20: Factor VIII deficiency treatment market revenue by geography 2016-2021 (%)
Exhibit 21: Market scenario in Americas
Exhibit 22: Factor VIII deficiency treatment market in Americas 2016-2021 ($ billions)
Exhibit 23: Market scenario in EMEA
Exhibit 24: Factor VIII deficiency treatment market in EMEA 2016-2021 ($ billions)
Exhibit 25: Market scenario in APAC
Exhibit 26: Factor VIII deficiency treatment market in APAC 2016-2021 ($ billions)
Exhibit 27: Incidence rates of factor VIII deficiency
Exhibit 28: YoY shipments of factor VIII units 2012-2016 (million units)
Exhibit 29: Impact of drivers
Exhibit 30: Diagnosis and treatment trends of hemophilia A 2013
Exhibit 31: Percentage share of diagnosed and undiagnosed hemophilia population 2012-2016
Exhibit 32: Forcefield analysis of drivers and challenges
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Competitive structure analysis of global factor VIII deficiency treatment market 2016
Exhibit 35: Competitive analysis of global factor VIII deficiency treatment market
Exhibit 36: Market share analysis 2016
Exhibit 37: Market penetration of various factor VIII manufacturers worldwide 2016
Exhibit 38: Strategic success factors of companies in global factor VIII deficiency treatment market
Exhibit 39: Key highlights
Exhibit 40: Bayer HealthCare: Strength assessment
Exhibit 41: Bayer HealthCare: Strategy assessment
Exhibit 42: Bayer HealthCare: Opportunity assessment
Exhibit 43: Bayer HealthCare: YoY revenue and growth rate of Kogenate 2013-2015 ($ billions)
Exhibit 44: Key highlights
Exhibit 45: CSL: Strength assessment
Exhibit 46: CSL: Strategy assessment
Exhibit 47: CSL: Opportunity assessment
Exhibit 48: Key highlights
Exhibit 49: Grifols: Strength assessment
Exhibit 50: Grifols: Strategy assessment
Exhibit 51: Grifols: Opportunity assessment
Exhibit 52: YoY growth rate and revenue of bioscience segment 2013-2015 ($ billions)
Exhibit 53: Key highlights
Exhibit 54: Novo Nordisk: Strength assessment
Exhibit 55: Novo Nordisk: Strategy assessment
Exhibit 56: Novo Nordisk: Opportunity assessment
Exhibit 57: Novo Nordisk: YoY revenue and growth of hemophilia segment 2013-2015
Exhibit 58: Key highlights
Exhibit 59: Pfizer: Strength assessment
Exhibit 60: Pfizer: Strategy assessment
Exhibit 61: Pfizer: Opportunity assessment
Exhibit 62: Pfizer: YoY revenue and growth rate of Xyntha/ReFacto AF 2013-2015 ($ millions)
Exhibit 63: Key highlights
Exhibit 64: Shire: Strength assessment
Exhibit 65: Shire: Strategy assessment
Exhibit 66: Shire: Opportunity assessment
Exhibit 67: Baxalta: YoY revenue comparison of hemophilia segment 2013-2015 ($ billions)
Exhibit 68: Baxalta: Geographic segmentation of hemophilia by revenue 2015


【レポート販売概要】

■ タイトル:第VIII因子欠乏症治療の世界市場2017-2021
■ 英文:Global Factor VIII Deficiency Treatment Market 2017-2021
■ 発行日:2017年3月6日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12140
■ 調査対象地域:グローバル
  • 検査機の世界市場展望2017-20276
    According to Stratistics MRC, the Global Inspection Machine Market is accounted for $531.80 million in 2017 and is expected to reach $994.27 million by 2026 growing at a CAGR of 7.2% during the forecast period. The growing number of regulatory mandates in the healthcare industry to continue compliance with superior manufacturing practices, an increasing number of inspection checkpoints throughout …
  • 世界における卵巣がん検査製品のパイプライン動向2015
    Ovarian Cancer - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Ovarian Cancer - Pipeline Review, 2015" provides an overview of Ovarian Cancer diagnostic tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players inv …
  • 歯科用CAD/CAMシステムの世界市場2015-2019
    About Dental CAD/CAM Dental CAD/CAM systems enable dentists to develop dental restorations with precision. They enhance the quality of dental prostheses including crowns, veneers, inlays and outlays, bridges and restorations. Dental CAD/CAM systems complement conventional technologies, which were used to perform various dental procedures. TechNavio's analysts forecast the Global Dental CAD/CAM mar …
  • 世界のスポーツ医療市場分析及び予測
    MediPoint: Sports Medicine - Global Analysis and Market Forecasts Summary This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and …
  • 院内感染検査の世界市場:UTI、SSI、肺炎球菌感染、血流感染、MRSA
    About Hospital-acquired Diseases Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstrea …
  • 代用骨移植片:グローバル市場分析と予測
    MediPoint: Bone Grafts and Substitutes - Global Analysis and Market Forecasts Summary Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general pictur …
  • MEG Energy Corp.:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    MEG Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary MEG Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
  • 米国のスマート教育市場2016-2020
    About Smart Education A technology-driven education system like the smart education architecture includes information, resources, and professional development opportunities to support institutions in imparting education to students in a digitally rich environment. In this system, traditional teaching methodologies are transformed to improve the learning process and knowledge delivery. The smart ed …
  • ブルキナファソの通信、モバイル、ブロードバンド市場
    Executive summary Airtel launches an m-health insurance service, following success in Ghana This report provides a comprehensive overview of trends and developments in Burkina Faso’s telecommunications market. Subjects covered include: Key statistics; Market and industry overviews; The impact of the global economic crisis; Regulatory environment and structural reform; Government policies affecting …
  • 航空機内装構造用コア材料の世界市場:ハニカム、フォーム、バルサ
    The global structural core material market in aerospace interior is projected to grow from USD 142.2 Million in 2016 to USD 220.2 Million by 2021, at a compound annual growth rate (CAGR) of 9.13% during the same period. The structural core material market in aerospace interior is growing because of increasing demand from different applications of aerospace interior. The market witnessed a strong g …
  • 患者登録ソフトウエアの世界市場:集団健康管理、患者ケア管理、ポイント・オブ・ケア
    The patient registry software market is expected to reach $610.8 million by 2019 from $381.0 million in 2014, at a CAGR of 9.9%. The global patient registry software market is categorized on the basis of delivery model, product type, database type, functionality, end user, and region. The subscription models segment is expected to register the highest growth rate in the patient registry software m …
  • ゲームの世界市場2016-2020
    About Gaming Earlier, gaming was limited to board games and handheld video games. The growing popularity of PCs and electronic devices aided by the increased internet penetration has led to the development and commercialization of games. Consumers are now heavily dependent on interactive entertainment such as video games. Video games are electronic games that require a video interface for human in …
  • 世界のデジタル・サイネージ市場動向及び予測(2014 – 2020)
    Digital signage refers to any of the electronic display that broadcasts television programming, menus, information, advertising, and other contents. Digital signs utilizing technologies such as LCD, LED, plasma displays, or projected images to display content is found in both public and private environments, including retail stores, hotels, restaurants, and corporate buildings, amongst other locat …
  • 世界の軍事衛星市場2015-2025
    Summary The Global Military satellite Market2015-2025 report, published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The globalMilitary satellite marketis expected to be …
  • 世界のマルチテナント・ホールセール・データセンター市場(2014-2018)
    TechNavio's analysts forecast the Global Multi-tenant Wholesale Data Center market to grow at a CAGR of 8.98 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing need to reduce capital and operational expenditure. The Global Multi-tenant Wholesale Data Center market has also been witnessing the adoption of high-density computing equipment. How …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。